Another study showed that CCDC3 can inhibit migration and invasion of prostate cancer cells, suggesting that CCDC3 possesses anticancer actions in prostate cancer (Ke et al., 2022), similar to its tumor-suppressive role in BrC (Li et al., 2023a; Figure 3). Here, CCDC3 is linked to prostate cancer.